Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
25.1 USD | -1.32% | -0.83% | -40.23% |
06-03 | Oppenheimer Adjusts Immunovant Price Target to $46 From $50, Maintains Outperform Rating | MT |
05-30 | Sector Update: Health Care Stocks Mixed Pre-Bell Thursday | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-40.23% | 3.71B | |
+53.19% | 59.28B | |
+41.42% | 40.94B | |
-5.60% | 40.17B | |
-5.16% | 28.69B | |
+12.69% | 26.63B | |
-20.80% | 18.89B | |
+30.40% | 12.46B | |
+0.08% | 12.42B | |
+26.19% | 12.26B |
- Stock Market
- Equities
- IMVT Stock
- News Immunovant, Inc.
- Insider Sell: Immunovant